Could leptospirosis leave lasting damage? a new study investigates

NCT ID NCT05436756

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study looks at whether people who had leptospirosis, a bacterial infection spread by animals, may have health problems that last for years after the initial illness. Researchers in Reunion will follow about 200 patients who were previously hospitalized with the disease, checking for symptoms like chronic fatigue, kidney issues, muscle weakness, and vision problems. By collecting blood and urine samples and asking about quality of life, the study aims to understand how common these long-term effects are and what they might mean for patient care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Biological sampling and collection (blood and urine samples) with clinical data collection
What this could lead to
If this study finds that many survivors have lasting symptoms, it could lead to better long-term care and monitoring for leptospirosis patients.
What could go wrong
This is an observational study, so it cannot prove what causes long-term symptoms. The results may not apply to other regions, and the follow-up may miss some cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEPTOSPIROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHOR

    Saint-Paul, France

  • CHU de la Réunion

    Saint-Denis, 97400, Reunion

  • DIALLO

    Saint-Pierre, 97410, France

  • GHER

    Saint-Benoît, 97470, Reunion

More trials for these conditions

Other studies related to the condition(s) this trial covers.